Faculty of Medicine and Dentistry, University of Alberta, Edmonton, AB.
Faculty of Medicine and Dentistry, University of Alberta, Edmonton, AB.
Can J Ophthalmol. 2023 Aug;58(4):318-323. doi: 10.1016/j.jcjo.2022.02.015. Epub 2022 Mar 18.
A central retinal artery occlusion (CRAO) represents a form of ocular stroke with poor visual prognosis. CRAO shares a common pathophysiology with cerebral ischemic stroke but presents unique diagnostic and management challenges leading to variability in clinical practice. This study aims to assess the presentation, treatment, and outcomes of CRAO at a tertiary care centre in Canada over 2 years and elucidate potential areas for improvement in the care of these patients.
Single-institution retrospective review including 27 patients diagnosed with CRAO from March 2018 to March 2020 in Edmonton, Alberta.
Most patients with CRAO presented to eye care providers (14 of 27); others presented to the emergency department (10 of 27) or family physicians (2 of 27). Three patients (11.1%) presented within 4.5 hours of symptom onset. At presentation, 81% of patients had visual acuity of 20/400 or worse in the affected eye. No patients received thrombolysis. The majority of CRAO cases had a nonarteritic etiology (92.6%). All patients had at least one pre-existing vascular risk factor. Forty-eight percent of patients received escalated medical therapy. Ipsilateral carotid stenosis was identified in 5 patients (18.5%); 3 patients required carotid endarterectomy. Two patients were diagnosed with atrial fibrillation. Two patients experienced symptomatic cerebral ischemia within 6 weeks of CRAO.
The majority of patients with CRAO presented to eye care providers, and few present within the potential window for thrombolysis of 4.5 hours, highlighting the need for public awareness strategies. Our cohort highlights the significant rate of systemic comorbidity that exists in these patients.
视网膜中央动脉阻塞(CRAO)是一种眼部卒中,其预后较差。CRAO 与脑缺血性卒中具有共同的病理生理学,但存在独特的诊断和管理挑战,导致临床实践存在差异。本研究旨在评估加拿大一家三级护理中心在 2 年内 CRAO 的表现、治疗和结局,并阐明改善这些患者治疗的潜在领域。
单中心回顾性研究,纳入 2018 年 3 月至 2020 年 3 月在艾伯塔省埃德蒙顿被诊断为 CRAO 的 27 例患者。
大多数 CRAO 患者就诊于眼科医生(27 例中的 14 例);其他患者就诊于急诊部(27 例中的 10 例)或家庭医生(27 例中的 2 例)。3 例(11.1%)患者在症状发作后 4.5 小时内就诊。就诊时,81%的患者患眼视力低于 20/400。无患者接受溶栓治疗。大多数 CRAO 病例的病因是非动脉炎性(92.6%)。所有患者均存在至少一种既往血管危险因素。48%的患者接受了强化药物治疗。5 例(18.5%)患者同侧颈动脉狭窄;3 例患者需要颈动脉内膜切除术。2 例患者被诊断为心房颤动。2 例患者在 CRAO 后 6 周内发生症状性脑缺血。
大多数 CRAO 患者就诊于眼科医生,很少有患者在 4.5 小时的溶栓治疗潜在窗口期内就诊,这突显了公众意识策略的必要性。本研究队列突出了这些患者存在的显著系统性合并症发生率。